Cardiorenal syndrome: an overview

C Ronco, A Bellasi, L Di Lullo - Advances in chronic kidney disease, 2018 - Elsevier
It is well established that a large number of patients with acute decompensated heart failure
present with various degrees of heart and kidney dysfunction usually primary disease of …

Cardiorenal syndrome

C Ronco, M Haapio, AA House, N Anavekar… - Journal of the American …, 2008 - jacc.org
The term cardiorenal syndrome (CRS) increasingly has been used without a consistent or
well-accepted definition. To include the vast array of interrelated derangements, and to …

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative

C Ronco, P McCullough, SD Anker, I Anand… - European heart …, 2010 - academic.oup.com
A consensus conference on cardio-renal syndromes (CRS) was held in Venice Italy, in
September 2008 under the auspices of the Acute Dialysis Quality Initiative (ADQI). The …

Chronic kidney disease and cardiovascular complications

L Di Lullo, A House, A Gorini, A Santoboni, D Russo… - Heart failure …, 2015 - Springer
Cardiovascular diseases such as coronary artery disease, congestive heart failure,
arrhythmias and sudden cardiac death represent main causes of morbidity and mortality in …

Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis

B Lilleness, FL Ruberg, R Mussinelli… - Blood, The Journal …, 2019 - ashpublications.org
Immunoglobulin light chain amyloidosis (AL amyloidosis) is caused by misfolded light
chains that form soluble toxic aggregates that deposit in tissues and organs, leading to …

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of …

JGF Cleland, JJV McMurray, J Kjekshus… - Journal of the American …, 2009 - jacc.org
Objectives: We investigated whether plasma amino-terminal pro-brain natriuretic peptide
(NT-proBNP), a marker of cardiac dysfunction and prognosis measured in CORONA …

Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide: a mechanistic study in hypertensive subjects

RRJ Van Kimmenade, JL Januzzi, JA Bakker… - Journal of the American …, 2009 - jacc.org
Objectives: This study sought to compare the renal clearance mechanisms of B-type
natriuretic peptide (BNP) and amino terminal pro-B-type natriuretic peptide (NT-proBNP) …

Soluble ST2 serum concentration and renal function in heart failure

A Bayes-Genis, E Zamora, M De Antonio, A Galán… - Journal of cardiac …, 2013 - Elsevier
Abstract Background Soluble ST2 (sST2) provides important prognostic information in
patients with heart failure (HF). How sST2 serum concentration is related to renal function is …

Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure

G Palladini, A Foli, P Milani, P Russo… - American journal of …, 2012 - Wiley Online Library
In AL amyloidosis prognosis depends on the severity of heart dysfunction which is best
assessed by natriuretic peptides (BNP and NT‐proBNP). However, their clearance relies on …

Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study

T Keller, CM Messow, E Lubos, V Nicaud… - European heart …, 2009 - academic.oup.com
Aims Chronic kidney disease is associated with increased risk of cardiovascular disease.
Cystatin C is a promising marker to reliably mirror renal function. The role of cystatin C in …